These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 1708234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK, Yoo JK, Webb DJ, Gonias SL.
    Biochem J; 1993 Feb 01; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
    Hall SW, Humphries JE, Gonias SL.
    J Biol Chem; 1991 Jul 05; 266(19):12329-36. PubMed ID: 1712017
    [Abstract] [Full Text] [Related]

  • 5. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
    Gonias SL, Figler NL, Braud LL.
    Blood; 1988 Nov 05; 72(5):1658-64. PubMed ID: 2460159
    [Abstract] [Full Text] [Related]

  • 6. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK, Wolf B, Gonias SL.
    Thromb Res; 1990 Aug 01; 59(3):449-62. PubMed ID: 1700488
    [Abstract] [Full Text] [Related]

  • 7. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.
    Gonias SL, Figler NL.
    Biochem J; 1988 Oct 15; 255(2):725-30. PubMed ID: 2462416
    [Abstract] [Full Text] [Related]

  • 8. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K, Komorowicz E, Machovich R.
    Blood Coagul Fibrinolysis; 1994 Dec 15; 5(6):905-11. PubMed ID: 7534486
    [Abstract] [Full Text] [Related]

  • 9. Interaction of human plasmin with human alpha 2-macroglobulin.
    Cummings HS, Castellino FJ.
    Biochemistry; 1984 Jan 03; 23(1):105-11. PubMed ID: 6197993
    [Abstract] [Full Text] [Related]

  • 10. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K, Léránt I, Tenekejiev K, Machovich R.
    J Biol Chem; 1994 Jun 24; 269(25):17030-4. PubMed ID: 7516329
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of plasmin by fibrinogen.
    Higazi AA, Mayer M.
    Biochem J; 1990 Jul 15; 269(2):299-302. PubMed ID: 2143650
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
    Humphries JE, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1993 Jan 15; 13(1):48-55. PubMed ID: 7678497
    [Abstract] [Full Text] [Related]

  • 13. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR, Van Hoef B, Matsuo O, Collen D.
    Biochim Biophys Acta; 1992 Jan 09; 1118(2):144-8. PubMed ID: 1730031
    [Abstract] [Full Text] [Related]

  • 14. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D, Anglés-Cano E.
    Biochem J; 1990 Oct 01; 271(1):51-7. PubMed ID: 1699517
    [Abstract] [Full Text] [Related]

  • 15. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.
    Anonick PK, Vetter WH, Gonias SL.
    Biochem J; 1989 Dec 15; 264(3):745-52. PubMed ID: 2482733
    [Abstract] [Full Text] [Related]

  • 16. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI.
    Thromb Haemost; 2001 Mar 15; 85(3):502-8. PubMed ID: 11307822
    [Abstract] [Full Text] [Related]

  • 17. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN, Cercek B, Lew AS, Ganz W.
    Thromb Res; 1986 Mar 01; 41(5):671-80. PubMed ID: 2421434
    [Abstract] [Full Text] [Related]

  • 18. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1992 Jun 01; 12(6):708-16. PubMed ID: 1375508
    [Abstract] [Full Text] [Related]

  • 19. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M, Brufatto N, Neill E, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13340-5. PubMed ID: 14715654
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP, Wohl RC, Boreisha IG, Robbins KC.
    Biochemistry; 1988 Sep 20; 27(19):7506-13. PubMed ID: 2974723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.